Evidence map›Paper›PMID 42698932›Full record

ArticleAfrican journal of laboratory medicine2026

Melissa V Bergman, Jean F Kloppers, Phillip A Bester, Anne-Cecilia van Marle

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in African journal of laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Melissa V BergmanDepartment of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.ORCID https://orcid.org/0000-0002-2187-3463
Jean F KloppersDepartment of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.ORCID https://orcid.org/0000-0002-8148-1242
Phillip A BesterNational Health Laboratory Service, Bloemfontein, South Africa.ORCID https://orcid.org/0000-0002-5795-5313
Anne-Cecilia van MarleDepartment of Haematology and Cell Biology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.ORCID https://orcid.org/0000-0002-6569-4061

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In patients with acute myeloid leukaemia (AML), pathogenic variants in the Objective: We determined the prevalence of Methods: The study included 40 participants with de novo AML and 100 elderly participants (≥ 65 years). Polymerase chain reactions and Oxford nanopore sequencing of Results: Of the 40 AML participants, 25 (62.5%) were women, with a median age of 42 years. Conclusion: The prevalence of What this study adds: Routine

Indexed as

acute myeloid leukaemiaadditional sex combs-like 1adverse prognostic featuresASXL1clonal haematopoiesis of indeterminate potentialepigenetics

Identifiers

PMID42698932
PMCPMC13543118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.